In a previous publication (1) it was shown that 25 mgms. of imipramine t given at 8 p.m. significantly reduced nocturnal enuresis in a group of 12 dis turbed children aged six to 12 years. At the time of completion of that investiga tion only one other controlled trial had obtained similar results (7) . Since then eight further reports have appeared (2-6, 8, 9, 10) of which six were doubleblind studies. Three of these concluded there were no significant differences be tween drug and placebo. The first two (2, 5) used young adult subjects aged 17 to 25 and 17 to 20 years. The trials were exceedingly 'brief, only two weeks and ten days respectively. In the third (10) the patients were nine children and drug lowered enuresis. The reduction on placebo, however was sufficient to bring the placebo/drug difference below the level of significance. In the remaining three investigations imipramine control led enuresis successfully. Poussaint and Ditman (9) studied 47 children aged five to 16 years over an eight-week trial and found a highly significant drug influence with 69% better on drug than placebo. The patients were referred from pedia tric and psychiatric out-patient depart ments 'and from private practitioners. Meijer (6) reported the drug reduced enuresis in a group of 12 children with serious orthopaedic handicaps aged seven to 14 years. Noach (8) studied 44 enuretics whose average age was 94 years and concluded imipramine was effective.
Previously reported studies have used 25 mgms. imipramine for children aged six to 12 years and 50 mgms. for those over 12 years. The drug has been given within one hour of bedtime, presumably on the assumption that this would pro duce optimum results. The first study (1) however, suggested that this might not be so since when given at bedtime imipramine reduced incidents before 1 a.m. less successfully than those after. It is not sufficient to determine if a drug is effective; the conditions under which maximum benefit may be obtained must be established. An in-patient setting offers the opportunity for controlled ob servations not readily achieved with an out-patient population.
This investigation seeks to confirm that imipramine significantly improves enuresis and more specifically to deter mine whether time of administration bears a significant relationship to effect.
Method a) Subjects:
These were 12 boys aged 7 years 3 months to 10 years 5 months at the start of the study, with a median age of 8 years 10 months. Eleven were diagnosed character disorder and had long-standing behavioural difficulties related to highly unfavourable environmental conditions. One patient (No. 3) was a borderline schizophrenic. Subjects were added to the investigation as they became avail able.
b) Experimental Design:
The study was double blind, using imipramine 25 mgms. and matching placebo. Each subject served as his own control. Three drug conditions each of four weeks were used; A : imipramine 25 mgms. The previous investigation had de monstrated that drug action was clearly evident five hours after administration; 3:15 p.m. allowed an equivalent interval prior to bedtime. It was also a convenient time in terms of hospital program. School was over then but group activities which were outside during the finer weather had not begun. This time avoided the child-care staff having to give medica tion during such an activity and so per mitted the time of administration by the nurse to be known with accuracy.
Each drug condition was preceded by a two-week placebo period (pa, pb, pc) in which tablets were given at the same time as during the corresponding drug period. Following this final drug condi tion a fourth two-week placebo period (pd) continued the time schedule of that drug condition. A four-week period of no medication observation occurred at the beginning (Ni) and end (N) of the trial, which therefore extended over 28 weeks. Children were randomly assigned to each of the six possible drug condition sequences.
Observations were made by the childcare staff at 12:30 a.m. and at 6 a.m. If found wet these times were recorded unless the child had woken and reported the enuresis. In that event the time of reporting was noted. Days on which medication was given 30 minutes or more late were excluded from the study as were nights away from the 'hospital.
Hypotheses:
It was predicted that: 1) Earlier drug administration would reduce enuretic incidents before 1 a.m. more than later dosage. 2) Earlier given drug would be more effective before than after 1 a.m. 3) Later drug administration would re duce incidents after 1 a.m. more than earlier dosage. 4) Later given drug would be more ef fective after than before 1 a.m. 5) Medication given early and late would be more effective both before and after 1 a.m. and would control enuretic nights more successfully, than either condition alone. 6) The relative effectiveness for indivi dual patients of early or late admin istration on enuretic nights would be determined by the proportion of early to late incidents.
Results:
For the total group, enuresis on place bo occurred on 379 of 586 nights, or 64.68% and on the drug on 423 of 863 nights or 49.02%. The drug produced therefore a reduction of 24.21% in place bo level. This was highly significant and was the only significant difference be tween the experimental conditions (Table I ). The average percentage of enuretic nights per child on placebo (64.25%) fell to an average on the drug of 49.39%, a decline in placebo level of 23.13%.
Individual results appear in Table II . A placebo response occurred in patient No. 3, but ceased on stopping placebo. Comparison of total days on the drug and placebo showed a significant fall in enuresis on the drug in five patients. Per centage reductions of placebo level ranged from 27.72% to 55.95% with a median value of 40.80%. A sixth patient (No. 2) enuretic 13 of 19 nights during observation and 9 of 11 nights on the first placebo period, responded as soon as the drug was given (condition B) and was enuretic only 15 times during the remaining 101 days of the trial. Com parison of total drug and placebo periods for this patient therefore shows no signi ficant difference (x 3 = 0.997). Reduction on the drug compared with the first placebo period was highly significant (p = < .001) with a decline in placebo level of 71.63%. In two patients (Nos. 2 and 12) enuresis remained significantly lowered during the N 2 period compared with Ni. Enuresis was significantly worse for the N 2 compared with the Ni period for patients 4 and 5.
Using the Friedman two-way analysis of variance, no significant differences 
FIGURE 1. Reduction in incidents before and after 1 a.m. and in enuretic nights per 100 days for total group for conditions A, B and C.
The changes in incidents and enuretic nights per 100 days are shown in Figure  1 and the levels of significance of the results in Table III . It will be seen that the fall in incidents and enuretic nights on condition A did not reach the 0.05 level of significance, condition B signi ficantly controlled incidents before 1 a.m. and enuretic nights but not inci dents after 1 a.m. and condition C had a significant effect on all three measures.
For the total group therefore 25 mgms. imipramine given at 3:15 p.m. was slight ly more successful in reducing enuretic nights than the same dose given at 8 p.m. but after 1 a.m. tihe influence of early medication declined. Examination of the number of incidents before and after 1 a.m. for each child showed that the group was composed of six early enuretics, whose incidents before 1 a.m. equalled one quarter or more of total incidents, and six late enuretics whose early incidents were fewer than this. Enuretic nights were lowered signifi cantly for the early type of enuresis on B condition (p = 0.025 Wilcoxon Test, one tailed) with an average decline of 
LEVELS OF SIGNIFICANCE OF ENURETIC INCIDENT REDUCTION FOR EACH DRUG CONDITION (WILCOXON MATCHED PAIRS SIGNED RANKS TEST -ONE TAILED).

Drug Condition Enuretic Incidents Total _ Enuretic Nights
Drug Condition
Before 1 a.m. After 1 a.m. 19.01 nights per 100 days. Condition A reduced enuresis in three patients with an average improvement of only 0.07 nights per 100 days. For the late enure tics condition A significantly controlled enuretic nights (p = 0.025 Wilcoxon Test, one tailed) with an average fall per 100 days of 25.47 nights. Condition B was without significant effect, pro ducing a decline in only four patients and an average reduction of 4.91 nights per 100 days. • The greater effectiveness of early medication in the early enuretic and of later administration in the late enuretic is illustrated in Figure 2 . This shows the decline in enuretic nights per 100 days on B condition minus chat on A condi tion, a positive difference indicating therefore a greater reduction on B than A. A positive difference is present in five of six early enuretics and a negative dif ference in the same number of late enu retics.
Total _ Enuretic Nights
Condition C was the most effective of the three conditions on individual patients. In addition to the five previous ly mentioned, a significant response was observed in two patients (Nos. 7 and 9, Table II ); the lesser influence of condi tions A and B resulted in a lack of signi ficant enuresis control when the three conditions were combined. Percentage reductions in placebo levels on C condi tion varied from 23.08% to 90.45%, with a median value of 55.89%. Condition A significantly improved two late enure tics (patients 10 and 12; for both p = < .01) with placebo levels lowered by 35.50% and 79.52% respectively. In three early enuretics, condition B was effective (cases 1 and 8 p = < .01, and case 5 p = < .02). Placebo levels were reduced in these patients by 52.65%, 43.84%, and 46.67% respectively. No drug side effects were observed at any time during the investigation.
Discussion
This study confirmed chat imipramine significantly controls nocturnal enuresis. As would be expected condition C had a greater effect than A or B or combined conditions and produced a significant result in eight patients. It is uncertain why patient No. 5 responded to condi tion B but not to C. However the effect of non-drug variables is most likely to be apparent when individual patients are studied for short periods. Relapse oc-curred when the drag was discontinued in all but two of those who responded, a finding which has been previously re ported (1, 6, 7) . Poussaint and Ditman however found that a majority of those becoming dry during the trial and main tained on the drug remained so follow ing gradual drug withdrawal.
Hypotheses I, II, V and VI were con firmed. Results were in the direction predicted by hypotheses III and IV but did not reach the 0.05 level of signifi cance. The findings clearly show that the greatest decline in enuretic nights will be obtained by early administration for early enuretics and later dosage for late enuretics. By simply relating time of medication to type of enuresis, reduc tion in enuretic nights per 100 days was improved from 11.56 to 25.47 on A, and from 12.62 to 19.01 on B. It is possible that some of the reported negative find ings with imipramine given at bedtime have resulted from the chance inclusion of a large proportion of early enuretics. The larger this proportion becomes the less likely will it be that late administra tion will produce a significant response. In this study condition A had no signifi cant effect on enuretic nights for the whole group, but did when only the late enuretics were considered.
These results indicate that although condition C most successfully control led enuresis, maximum effect from 50 mgms. imipramine will not be obtained in this way. For the late enuretic, for example, the early dose has lost some of its action by the time enuresis occurs. It would be expected that 50 mgms. given at 3:15 or 8 p.m. depending on the type of enuresis would offer better control than condition C.
It is concluded that greatest benefit from imipramine is to be obtained by relating time of administration to type of enuresis.
Resume
Une etude anterieure a montr6 qu'une dose de 25 mg d'imipramine, administree a 8h. du soir a diminue les cas d'enuresie apres une heure du matin, plus qu'une dose administree anterieurement. L'etude actuelle cherchait a confirmer que l'imipramine exercait un effet significatif sur l'enuresie nocturne chez les enfants et a determiner le rapport de l'heure d'administration avec 1'effet obtenu. nocturne qu'une administration a l'un ou a l'autre moment; (6) que l'efficacite relative de I'administration precoce ou tardive sur l'enuresie de sujets particuliers serait determinee par le nombre de cas d'enuresie precoce par rapport au nombre de cas.d'enuresie tardive.
Les suppositions 1, 2, 5 et 6 se sont vu confirmees et les resultats ont pris la direction attendue qu'avaient predite les suppositions 3 et 4, mais ils n'ont pas atteint le niveau de 0.05 de signification. L'efficacite de l'imipramine pour enrayer l'enuresie nocturne a ete confirmee. Le moment C a ete celui qui a eu le plus de succes et il y a eu baisse significative de l'enuresie chez huit sujets. Les reduc tions proportionnelles du niveau des pla cebos ont varie de 23.08 a 90.45 p. 100, avec valeur moyenne de 55.89 p. 100. Des rechutes se sont produites chez six de ces sujets lorsqu'on a cesse I'administration du medicament.
Le moment A a diminue de fagon si gnificative le nombre de cas d'enuresie nocturne pour le groupe enuretique tardif (les cas avant une heure du matin ont ete inferieurs au quart du total) mais cela n'a pas joue pour l'ensemble du groupe.
Bien qu'il ait eu une influence significa tive sur les nuits d'enuresie pour l'ensem ble du groupe, le moment B a produit une baisse beaucoup plus accentuee chez les sujets dont l'enuresie etait plus precoce (cas anterieurs a une heure du matin, un quart et plus du total.) Chez cinq sur six sujets atteints d'enuresie, le moment B a reduit le nombre de nuits d'enuresie plus que le moment A, le contraire etant vrai des cas tardifs d'enurtsie.
On conclut que 50 mg d'imipramine, administree a 3h.l5 de l'apres-midi ou a 8h. du soir, selon le type d'enuresie seraient plus efficaces que le moment C. L'imipramine donne les meilleurs rtsultats lorsqu'on relie le moment de I'administra tion au genre d'enuresie.
